Strongbridge Biopharma plc
SBBP · NASDAQ
6/30/2021 | 3/31/2021 | 12/31/2020 | 9/30/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13,241 | -$11,814 | -$11,946 | -$3,159 |
| Dep. & Amort. | $1,277 | $1,277 | $1,277 | $1,276 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,082 | $2,277 | $1,787 | $2,070 |
| Change in WC | $423 | -$6,192 | $3,222 | $21,458 |
| Other Non-Cash | -$368 | $1,059 | $660 | -$27,404 |
| Operating Cash Flow | -$9,827 | -$13,393 | -$5,000 | -$5,759 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$10 | $0 | -$10 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$10 | $0 | -$10 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $38 | $729 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$297 | -$221 | $10,729 | $27,653 |
| Financing Cash Flow | -$297 | -$221 | $10,729 | $27,653 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$10,124 | -$13,624 | $5,729 | $21,884 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $73,898 | $87,522 | $81,793 | $59,909 |
| End Cash | $63,774 | $73,898 | $87,522 | $81,793 |
| Free Cash Flow | -$9,827 | -$13,403 | -$5,000 | -$5,769 |